#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Friedreich's ataxia Thalassaemia beta Vitamin B12 deficiency Desmoid tumour Acute graft versus host disease Hyperchylomicronaemia Post transplant lymphoproliferative disorder Neuroendocrine cell hyperplasia of infancy Epstein-Barr virus infection Intracranial calcification Rheumatoid arthritis Pericarditis Round cell liposarcoma Inclusion body myositis Burkitt's lymphoma More trials…

    Learn about Rare Diseases

    Nodal marginal zone B-cell lymphoma – Basic Information Chordoma – Diagnostics Systemic sclerosis pulmonary Rhabdomyosarcoma – Diagnostics Breast angiosarcoma metastatic – Treatment Angelman’s syndrome – Trials in Disease Splenic marginal zone lymphoma Hereditary motor and sensory neuropathy – Diagnostics CADASIL Medulloblastoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ruxolitinib HAFNIUM OXIDE Hdp-101 Nimotuzumab Paltusotine HYALURONIDASE Asciminib Hydrochloride Dapagliflozin Azelastine Roxadustat Lixisenatide Rugonersen Cd7-Cart01 Dexpanthenol 11902A Ambrisentan Acetylcysteine Amide Miglustat Fremanezumab Op-1250 More therapies…

    Learn about Your Condition

    Prostatitis Escherichia coli Plasma cell myeloma recurrent Klinefelter's syndrome Liposarcoma metastatic Retinitis pigmentosa Glycogen storage disorder Niemann-Pick disease Kidney transplant rejection Dry eye Rhinitis allergic Neuroblastoma recurrent Dedifferentiated liposarcoma Blood iron increased Essential thrombocythaemia Glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Heart transplant

  • Study on Preventing Heart Transplant Rejection in Children Using Autologous Treg Cells (thyTreg)

    Recruiting

    1 1 1
    Investigated Diseases:
    • Heart transplant
    Spain

  • Study comparing Custodiol-N and Custodiol organ preservation solutions for heart transplantation in children

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Heart transplant
    Investigated Drugs:
    • Aspartic Acid
    • Calcium
    • Chloride Ion
    Germany

  • Aspirin Resistance Testing in Patients 12 to 18 Months After Heart Transplantation Treated with Acetylsalicylic Acid

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Heart transplant
    Investigated Drugs:
    • Acetylsalicylic Acid
    Austria

  • Study on How Pantoprazole Affects the Absorption of Mycophenolate Mofetil in Post-Transplant Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Heart transplant
    • Liver transplant
    • Renal transplant
    Investigated Drugs:
    • Pantoprazole
    • Mycophenolate Mofetil
    The Netherlands

  • Study on Alirocumab for Preventing Heart Vessel Disease in Recent Heart Transplant Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Heart transplant
    Investigated Drugs:
    • Alirocumab
    Czechia

  • Study on Dapagliflozin for Kidney Protection in Heart Transplant Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Heart transplant
    • Renal failure
    Investigated Drugs:
    • Dapagliflozin
    The Netherlands Norway Sweden

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!